developed a carrier protein-based PCa detection platform where any antibody and Ni-NTA-functionalized nanoparticles can bind the target protein via protein G and 6*His-tag, respectively; the carriers are modified by the desferrin gene to form a unique probe, which diagnoses PCa cells by detecting claudin-4 (83). The gene discussed is CLDN4; the disease is posterior cortical atrophy.